REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Chongqing Genrix Biopharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chongqing Genrix Biopharmaceutical Co., Ltd. Profile Updated: May 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Chongqing Genrix Biopharmaceutical Co.,ltd. is engaged in the research and development, production and sales of antibody drugs. The company's research products are monoclonal antibody drugs and bispecific antibody drugs. The company was established in 2015 and is headquartered in Chongqing City, China.

Headquarters
No. 699, Maliu Avenue, Banan District, Chongqing
Chongqing; Chongqing; Postal Code: 401338

Contact Details: Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. report to view the information.

Website: http://www.genrixbio.com

Basic Information
Total Employees:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
October 20, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
54.54%
Purchase this report to view the information.
3.97%
Purchase this report to view the information.
3.13%
Purchase this report to view the information.
2.45%
Purchase this report to view the information.
1.7%
Subsidiaries
Beijing Zhirenmeibo Biotechnology Co., Ltd.
100%
Zhixiang (Shanghai) Pharmaceutical Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Chongqing Genrix Biopharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-93.67%▼
Total operating revenue
-98.25%▼
Operating profit (EBIT)
18.51%▲
EBITDA
18.73%▲
Net Profit (Loss) for the Period
18.51%▲
Total assets
282.65%▲
Total equity
N/A
Operating Profit Margin (ROS)
-2386161.88%▼
Net Profit Margin
-2386255.09%▼
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
21.28%▲
Cash Ratio
22.62%▲

Similar companies

Shanghai Pharmaceuticals Holding Co.,Ltd
 
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
 
Zjamp Group Co., Ltd.
Shouyao Holdings Co.,Ltd (首药控股(北京)股份有限公司)
 
Wuhan Yzy Biopharma Co. Ltd.
Shanghai Jiaoda Onlly Co.,Ltd
 
Inventisbio Co., Limited (益方生物科技(上海)股份有限公司)

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo